O. Michael Colvin
- Molecular Biology
- Oncology
- Genetics top 10%
- Organic Chemistry
- Public Health, Environmental and Occupational Health
- Co-authors
- Darell D. BignerHenry S. FriedmanStefan PauliLu YangLyndsay N. HarrisT S HsiehJ. Dirk IglehartVlayka Liotcheva
- Topics
- Glioma Diagnosis and Treatment (7 papers)Cancer Treatment and Pharmacology (3 papers)Cancer therapeutics and mechanisms (3 papers)
- Cited by
- GeneticsOncologyPharmacology
- Journals
- Analytical ChemistryInternational Journal of Radiation Oncology*Biology*PhysicsBiochemical Pharmacology
- Partner nations
- United StatesCanada
In The Last Decade
O. Michael Colvin
22 papers receiving 769 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 337
- Oncology 197
- Genetics 109
- Organic Chemistry 98
- Public Health, Environmental and Occupational Health 81
Countries citing papers authored by O. Michael Colvin
This map shows the geographic impact of O. Michael Colvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Michael Colvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Michael Colvin more than expected).
Fields of papers citing papers by O. Michael Colvin
This network shows the impact of papers produced by O. Michael Colvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Michael Colvin. The network helps show where O. Michael Colvin may publish in the future.
Co-authorship network of co-authors of O. Michael Colvin
This figure shows the co-authorship network connecting the top 25 collaborators of O. Michael Colvin. A scholar is included among the top collaborators of O. Michael Colvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Michael Colvin. O. Michael Colvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 40 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy. | 64 |
| 5 | 16 | |
| 6 | 194 | |
| 7 | 14 | |
| 8 | 15 | |
| 9 | 0 | |
| 10 | 37 | |
| 11 | 21 | |
| 12 | 3 | |
| 13 | 21 | |
| 14 | 7 | |
| 15 | 30 | |
| 16 | Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide. | 18 |
| 17 | 21 | |
| 18 | 16 | |
| 19 | 12 | |
| 20 | 18 |
About O. Michael Colvin
O. Michael Colvin is a scholar working on Genetics, Ophthalmology and Physiology, having authored 23 papers that have together received 790 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Genetics (109 citations), Oncology (197 citations) and Pharmacology (46 citations). O. Michael Colvin has collaborated with scholars based in United States and Canada. Frequent co-authors include Darell D. Bigner, Henry S. Friedman, Stefan Pauli, Lu Yang, Lyndsay N. Harris, T S Hsieh, J. Dirk Iglehart, Vlayka Liotcheva, Francis Ali‐Osman and James L. Wilmer. Their work appears in journals such as Analytical Chemistry, International Journal of Radiation Oncology*Biology*Physics and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.